These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 757622)

  • 1. [Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases].
    Polico C; Nascimben O; Maccari F; Fazzin G
    Quad Sclavo Diagn; 1978 Dec; 14(4):486-93. PubMed ID: 757622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses].
    Martoni A; Pedelini G; Colalongo G; Biagi R; Mambelli M; Jafelice G; Rocchetta G; Piana E; Pannuti F
    Minerva Med; 1980 Sep; 71(31):2215-9. PubMed ID: 7422143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
    Ditzel J; Jordal R; Riskoer N
    Ugeskr Laeger; 1968 Oct; 130(42):1766-71. PubMed ID: 5724711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
    Gasser AB; Depierre D; Alberto P; Courvoisier B
    Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of bone-related biomarkers and CA27.29 to assess response to treatment of osseous metastatic breast cancer.
    Lüfter D; Richter A; Günther S; Flath B; Akrivakis C; Geppert R; Wernecke KD; Possinger K
    Anticancer Res; 2000; 20(6D):5099-105. PubMed ID: 11326676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of TPS and CA 15-3 assays for monitoring chemotherapy in metastatic breast cancer patients.
    Einarsson R; Lindman H; Bergh J
    Anticancer Res; 2000; 20(6D):5089-93. PubMed ID: 11326674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
    Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A
    Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyproline and zinc excretion in patients with neoplastic breast disease.
    Percudani M; Dell'Anna B; De Lorenzis GF; Ferraccioli GF; Vaona GL
    Int Surg; 1981; 66(3):233-6. PubMed ID: 7319736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
    Niell HB; Palmieri GM; Neely CL; McDonald MW
    Arch Intern Med; 1981 Oct; 141(11):1471-3. PubMed ID: 7283558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.
    Koda M; Lenczewski A; Sulkowska M; Kanczuga-Koda L; Wincewicz A; Tomaszewski J; Sulkowski S
    Oncol Rep; 2007 Feb; 17(2):385-91. PubMed ID: 17203178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mithramycin on widespread painful bone metastases in cancer of the breast.
    Davies J; Trask C; Souhami RL
    Cancer Treat Rep; 1979; 63(11-12):1835-8. PubMed ID: 93511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytostatic therapy of metastatic breast cancer].
    Mussa A; Dogliotti L; Musumeci SV; Linfanti CV; Alabiso O; Festa V; Giugno G; Sandrucci S; Benedetto G
    Minerva Chir; 1980 Aug 15-31; 35(15-16):1195-225. PubMed ID: 7005745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion. European Organization for Research and Treatment of Cancer.
    Vinholes J; Coleman R; Lacombe D; Rose C; Tubiana-Hulin M; Bastit P; Wildiers J; Michel J; Leonard R; Nortier J; Mignolet F; Ford J
    Br J Cancer; 1999 Apr; 80(1-2):221-8. PubMed ID: 10390000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydroxyprolinuria in relation to bone metastases in patients with breast cancer].
    Rico Lenza H; Millán Núñez-Cortés J; Rodríguez Mora VI; Espinós Pérez D
    Rev Esp Oncol; 1980; 27(1):61-6. PubMed ID: 7209108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic relief for patients with osseous metastasis treated with radiation and methylprednisolone: a prospective randomized study.
    Teshima T; Inoue T; Inoue T; Ikeda H; Murayama S; Yamazaki H; Ohtani M; Kishi K; Miyata Y
    Radiat Med; 1996; 14(4):185-8. PubMed ID: 8916260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability.
    Mouridsen H; Sun Y; Gershanovich M; Perez-Carrion R; Becquart D; Chaudri-Ross HA; Lang R
    Oncologist; 2004; 9(5):489-96. PubMed ID: 15477633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.